Clinically applicable strategy for early identification of IFN-AAB-positive COVID-19 patients

By | November 17, 2021
Researchers from the Humboldt-Universität zu Berlin have been investigating the presence of these antibodies in hospitalized COVID-19 patients to examine the potential of using them as a biomarker for severe disease.